ConvaTec Group (LSE:CTEC) Capital Expenditure : £-102.19 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

ConvaTec Group's cash flow for capital expenditures for the six months ended in Dec. 2023 was £-56 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was £-102.19 Mil.

ConvaTec Group Capital Expenditure Historical Data

The historical data trend for ConvaTec Group's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group Capital Expenditure Chart

ConvaTec Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-46.85

-64.13

-70.76

-118.39

-102.07

ConvaTec Group Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capital Expenditure	Get a 7-Day Free Trial														-37.98	-52.05	-65.76	-46.49	-55.70

ConvaTec Group Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-102.19 Mil.

ConvaTec Group (LSE:CTEC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (LSE:CTEC) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

CNVVF:USA CNVVY:USA CTECl:UK

Address

23 Forbury Road, 3 Forbury Place, Reading, GBR, RG1 3JH

Website

https://www.convatecgroup.com

Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.